Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

TOLMAR INC

Home Clinical Trial Sponsors and OrganizationsTOLMAR INC

TOLMAR INC

1575 Cedar Creek Dr, Dayton, Ohio, United States

Also known as:

Subway

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

8

3 active

Approvals

21

Total approvals

Agencies

3

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 3

3

37.5%

Not Applicable

2

25.0%

Phase 1

1

12.5%

Phase 4

1

12.5%

Trial Status Distribution

Active, not recruiting

2

25.0%

Completed

4

50.0%

Enrolling By Invitation

1

12.5%

Clinical Trials

Trials sponsored by this organization (8)

A Phase 4 Study to Evaluate Adrenal Function in Hypogonadal Men Treated With JATENZO® for 12 Months

Active, not recruiting

May 2024110 participants

Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study

Enrolling By Invitation

Dec 2022250 participants

Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer

Active, not recruiting

Jul 2021250 participants

BE Study of Calcipotriene Hydrate and Betamethasone Dipropionate Topical Suspension in the Treatment of Scalp Psoriasis

Apr 2017699 participants

Bioequivalence study of Doxorubicin Hydrochloride in Subjects with Epithelial Ovarian Carcinoma Who Have Failed Platinum-Based Chemotherapy

Dec 201660 participants

Study of Leuprolide Acetate Injectable Suspension in the Treatment of Central Precocious Puberty

Aug 201564 participants

A SINGLE-DOSE PHARMACOKINETIC AND BIOAVAILABILITY STUDY OF A GENERIC LIPOSOME-ENCAPSULATED DOXORUBICIN HYDROCHLORIDE FORMULATION IN SUBJECTS WITH EPITHELIAL OVARIAN CARCINOMA WHO HAVE FAILED PLATINUM-BASED CHEMOTHERAPY

Bioequivalence study of Doxorubicin Hydrochloride in Subjects with Epithelial Ovarian Carcinoma Who Have Failed Platinum-Based Chemotherapy

17 participants

Approvals

Approvals by Agency

FDA

Food and Drug Administration

15

Approvals

SFDA

Saudi Food and Drug Authority

3

Approvals

NPRA

National Pharmaceutical Regulatory Agency

3

Approvals

Recent Approvals

Paliperidone Palmitate

Paliperidone Palmitate

ELIGARD 7.5MG POWDER & SOLVENT FOR SOLUTION FOR INJECTION

ELIGARD 45MG POWDER & SOLVENT FOR SOLUTION FOR INJECTION

ELIGARD 22.5MG POWDER & SOLVENT FOR SOLUTION FOR INJECTION

ELIGARD 45 MG POWDER FOR SOLUTION FOR INJECTION

ELIGARD 7.5 MG POWDER FOR SOLUTION FOR INJECTION

ELIGARD 22.5 MG POWDER FOR SOLUTION FOR INJECTION

News

No news articles found

On this page

Overview
Clinical Trials8
Approvals21
News

Back to Organizations